Nauset Wealth Management’s AstraZeneca AZN Stock Holding History

Nauset Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$59K	Buy	+446	New	+$53.5K	0.05%	109

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Nauset Wealth Management's AZN Position: Q1 2022 in Review

Nauset Wealth Management opened a new position in AstraZeneca (AZN) in Q1 2022: 446 shares worth $59K. The stake represents 0.05% of the portfolio and ranks #109 among its holdings.

982 funds tracked by Wall St. Rank hold AZN as of Q1 2022.

Nauset Wealth Management held 446 shares of AstraZeneca worth $59K as of Q1 2022.
AstraZeneca was a new Nauset Wealth Management position in Q1 2022.
AstraZeneca made up 0.05% of Nauset Wealth Management's portfolio in Q1 2022, its #109 holding.
982 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2022.

Based on Nauset Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.